NCT04281667

Brief Summary

MOBILE2 is a randomized controlled trial comparing mechanical and oral antibiotic bowel preparation to mechanical bowel preparation only in patients undergoing anterior rectal resection with primary anastomosis. Primary endpoint is Comprehensive Complication Index within 30 days from surgery.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
604

participants targeted

Target at P75+ for phase_4

Timeline
17mo left

Started Mar 2020

Longer than P75 for phase_4

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Mar 2020Oct 2027

First Submitted

Initial submission to the registry

February 14, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 24, 2020

Completed
23 days until next milestone

Study Start

First participant enrolled

March 18, 2020

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 9, 2022

Completed
4.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2027

Expected
Last Updated

November 17, 2022

Status Verified

November 1, 2022

Enrollment Period

2.6 years

First QC Date

February 14, 2020

Last Update Submit

November 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comprehensive Complication Index

    Comprehensive Complication Index score

    Within 30 days from surgery

Secondary Outcomes (5)

  • Surgical Site Infection

    Within 30 days from surgery

  • Anastomotic dehiscence

    Within 30 days from surgery

  • Lenght of hospital stay

    Within hospital stay, estimated on average 7 days

  • Mortality

    Within 90 days from surgery

  • Adjuvant therapy

    Within 6 months from surgery

Other Outcomes (9)

  • 5-year overall survival

    5 years from surgery

  • 5-year disease specific survival

    5 years from surgery

  • 5-year recurrence free survival

    5 years from surgery

  • +6 more other outcomes

Study Arms (2)

Mechanical Bowel Preparation and Oral Antibiotics

EXPERIMENTAL

Mechanical Bowel Preparation and Oral Antibiotics

Drug: Oral AntibioticsDrug: Mechanical Bowel Preparation

Mechanical Bowel Preparation Only

ACTIVE COMPARATOR

Mechanical Bowel Preparation Only

Drug: PlaceboDrug: Mechanical Bowel Preparation

Interventions

Oral antibiotics (neomycin 1g and metronidazole 1g at 3pm and 11pm the day before surgery)

Mechanical Bowel Preparation and Oral Antibiotics

Oral placebos (placebo 1 and placebo 2 at 3pm and 11pm the day before surgery)

Mechanical Bowel Preparation Only

Mechanical Bowel Preparation using 2L polyethylene glycol (Moviprep)

Mechanical Bowel Preparation OnlyMechanical Bowel Preparation and Oral Antibiotics

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for anterior rectal resection with primary anastomosis

You may not qualify if:

  • Emergency operation
  • Bowel obstruction
  • Existing stoma
  • Other reason preventing mechanical bowel preparation
  • Allergy to neomycin or metronidazole
  • Age \< 18 years
  • Lack of co-operation
  • Patient did not undergo surgery
  • Anterior resection was not performed
  • Colonic anastomosis was not performed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Helsinki University Hospital

Helsinki, Finland

Location

Tampere University Hospital

Tampere, Finland

Location

Turku University Hospital

Turku, Finland

Location

Related Publications (4)

  • Koskenvuo L, Lunkka P, Varpe P, Hyoty M, Satokari R, Haapamaki C, Lepisto A, Sallinen V. Morbidity After Mechanical Bowel Preparation and Oral Antibiotics Prior to Rectal Resection: The MOBILE2 Randomized Clinical Trial. JAMA Surg. 2024 Jun 1;159(6):606-614. doi: 10.1001/jamasurg.2024.0184.

  • Willis MA, Toews I, Soltau SL, Kalff JC, Meerpohl JJ, Vilz TO. Preoperative combined mechanical and oral antibiotic bowel preparation for preventing complications in elective colorectal surgery. Cochrane Database Syst Rev. 2023 Feb 7;2(2):CD014909. doi: 10.1002/14651858.CD014909.pub2.

  • Koskenvuo L, Lunkka P, Varpe P, Hyoty M, Satokari R, Haapamaki C, Lepisto A, Sallinen V. Mechanical bowel preparation and oral antibiotics versus mechanical bowel preparation only prior rectal surgery (MOBILE2): a multicentre, double-blinded, randomised controlled trial-study protocol. BMJ Open. 2021 Jul 9;11(7):e051269. doi: 10.1136/bmjopen-2021-051269.

  • Koskenvuo L, Sallinen V. Preoperative oral antibiotics in colon surgery. Lancet Gastroenterol Hepatol. 2020 Sep;5(9):801-802. doi: 10.1016/S2468-1253(20)30203-X. No abstract available.

MeSH Terms

Conditions

Rectal NeoplasmsColorectal NeoplasmsSurgical Wound Infection

Interventions

Anti-Bacterial Agents

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesColonic DiseasesWound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anti-Infective AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Study Officials

  • Laura Koskenvuo, MD, PhD

    Helsinki University Central Hospital

    PRINCIPAL INVESTIGATOR
  • Anna Lepistö, MD, PhD

    Helsinki University Central Hospital

    STUDY CHAIR
  • Ville Sallinen, MD, PhD

    Helsinki University Central Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adj. Prof.

Study Record Dates

First Submitted

February 14, 2020

First Posted

February 24, 2020

Study Start

March 18, 2020

Primary Completion

November 9, 2022

Study Completion (Estimated)

October 10, 2027

Last Updated

November 17, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Individual deidentified participant data will not be available for sharing. Study protocol will be available.

Locations